iShares Biotechnology ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IBB and other ETFs, options, and stocks.

About IBB

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. 

Index-Tracked
NYSE Biotechnology TR USD
Index-TrackedNYSE Biotechnology TR USD
Category
Health
CategoryHealth
Number of holdings
253
Number of holdings253
Inception Date
Feb 5, 2001
Inception DateFeb 5, 2001

IBB Key Statistics

AUM
8.48B
AUM8.48B
Price-Earnings ratio
735.71
Price-Earnings ratio735.71
30-Day yield
0.01
30-Day yield0.01
Average volume
1.41M
Average volume1.41M
High today
$168.33
High today$168.33
Low today
$166.03
Low today$166.03
Open price
$166.89
Open price$166.89
Volume
908.62K
Volume908.62K
52 Week high
$174.40
52 Week high$174.40
52 Week low
$107.43
52 Week low$107.43
Expense ratio
0.44
Expense ratio0.44

Stock Snapshot

iShares Biotechnology ETF(IBB) stock is priced at $166.75, giving the company a market capitalization of 8.34B. It carries a P/E multiple of 735.71 and pays a dividend yield of 43.1%.

On 2025-12-18, iShares Biotechnology ETF(IBB) stock traded between a low of $166.03 and a high of $168.33. Shares are currently priced at $166.75, which is +0.4% above the low and -0.9% below the high.

The iShares Biotechnology ETF(IBB)'s current trading volume is 908.62K, compared to an average daily volume of 1.41M.

During the past year, iShares Biotechnology ETF(IBB) stock moved between $107.43 at its lowest and $174.40 at its peak.

During the past year, iShares Biotechnology ETF(IBB) stock moved between $107.43 at its lowest and $174.40 at its peak.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.